EdgarLookup

LEXICON PHARMACEUTICALS, INC. — All Filings

1,003 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-Q 10-Q/A 144 3 4 4/A 424B2 424B3 424B4 424B5 5 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A EFFECT FWP POS AM PRE 14A PRER14A RW S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
3 PRIMARY DOCUMENT 0001127602-25-017010 Jun 6, 2025 Jun 1, 2025
4 PRIMARY DOCUMENT 0001127602-25-016480 Jun 3, 2025
4 PRIMARY DOCUMENT 0001127602-25-016465 Jun 3, 2025
4 PRIMARY DOCUMENT 0001127602-25-016476 Jun 3, 2025
8-K 8-K 0001062822-25-000033 Jun 3, 2025 Jun 2, 2025
4 PRIMARY DOCUMENT 0001127602-25-016458 Jun 3, 2025
4 PRIMARY DOCUMENT 0001127602-25-016461 Jun 3, 2025
4 PRIMARY DOCUMENT 0001127602-25-016471 Jun 3, 2025
4 PRIMARY DOCUMENT 0001127602-25-016473 Jun 3, 2025
10-Q 10-Q 0001062822-25-000029 May 14, 2025 Mar 31, 2025
4 PRIMARY DOCUMENT 0001127602-25-014144 May 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-014145 May 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-014143 May 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-014139 May 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-014146 May 13, 2025
8-K 8-K 0001062822-25-000027 May 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-014140 May 13, 2025
SCHEDULE 13G/A 0000315066-25-001536 May 12, 2025
DEFA14A DEFA14A 0001062822-25-000024 Apr 22, 2025
ARS ARS 0001062822-25-000025 Apr 22, 2025 Dec 31, 2024
DEF 14A DEF 14A 0001062822-25-000023 Apr 22, 2025
8-K 8-K 0001062822-25-000019 Mar 28, 2025 Mar 27, 2025
PRE 14A PRE 14A 0001062822-25-000016 Mar 25, 2025 Mar 20, 2025
10-K 10-K 0001062822-25-000013 Mar 7, 2025 Dec 31, 2024
8-K 8-K 0001062822-25-000008 Mar 6, 2025
4 PRIMARY DOCUMENT 0001127602-25-007540 Mar 3, 2025 Feb 28, 2025
4 PRIMARY DOCUMENT 0001127602-25-007538 Mar 3, 2025 Feb 28, 2025
4 PRIMARY DOCUMENT 0001127602-25-007521 Mar 3, 2025 Feb 28, 2025
4 PRIMARY DOCUMENT 0001127602-25-007527 Mar 3, 2025 Feb 28, 2025
4 PRIMARY DOCUMENT 0001127602-25-007530 Mar 3, 2025 Feb 28, 2025
4 PRIMARY DOCUMENT 0001127602-25-007534 Mar 3, 2025 Feb 28, 2025
4 PRIMARY DOCUMENT 0001127602-25-005225 Feb 18, 2025 Feb 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-005221 Feb 18, 2025 Feb 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-005223 Feb 18, 2025 Feb 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-005209 Feb 18, 2025 Feb 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-005212 Feb 18, 2025 Feb 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-005213 Feb 18, 2025 Feb 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-005215 Feb 18, 2025 Feb 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-005218 Feb 18, 2025 Feb 13, 2025
4 PRIMARY DOCUMENT 0001127602-25-005220 Feb 18, 2025 Feb 13, 2025
8-K 8-K 0001062822-25-000005 Jan 7, 2025 Jan 3, 2025
8-K 8-K 0001062822-25-000003 Jan 2, 2025
3 PRIMARY DOCUMENT 0001127602-25-000080 Jan 2, 2025
4 PRIMARY DOCUMENT 0001127602-25-000084 Jan 2, 2025
3 3 0000950170-24-136814 Dec 16, 2024 Dec 5, 2024
SC 13D/A SC 13D/A 0001193125-24-273713 Dec 9, 2024
3 PRIMARY DOCUMENT 0001127602-24-028321 Dec 2, 2024
4 PRIMARY DOCUMENT 0001127602-24-028323 Dec 2, 2024
8-K 8-K 0001062822-24-000064 Nov 22, 2024
8-K 8-K 0001062822-24-000062 Nov 20, 2024 Nov 19, 2024